Wendy SiegelmanEx Cambridge Analytica exec Brittany Kaiser is CEO of AlphaTon Capital, previously named Portage Biotech, a cancer treatment company
Shares surged on news they are exploring merging blockchain technology with oncology innovation
What could possibly go wrong
My latest piece on Brittany Kaiser, her new gig as CEO of AlphaTON - and several connections the company has to Russia
AlphaTON shares surge 200% after unveiling digital asset-powered oncology initiative
Shares of AlphaTON Capital Corp (NASDAQ:ATON) soared 200% on Wednesday after the company announced plans to explore the tokenization of its mesothelioma treatment program, marking a first-of-its-kind effort to merge blockchain technology with oncology innovation. The company said it has signed a non-binding letter of intent to evaluate tokenizing the single-indication economics of its TT-4...